Development of Targeted Drug Delivery System for Breast Cancer

dc.contributor.guideMalairaman, Udayabanu
dc.coverage.spatial
dc.creator.researcherSharma, Arun
dc.date.accessioned2020-03-16T05:42:27Z
dc.date.available2020-03-16T05:42:27Z
dc.date.awarded10/02/2020
dc.date.completed2020
dc.date.registered05/08/2013
dc.description.abstractThe present investigation was aimed to develop a targeted co-delivery system of paclitaxel (PAX) and clotrimazole (CLZ) through polycaprolactone (PCL) nanoparticles (NPs). Sialic acid (SA) was employed to acquire active targeting towards breast cancer cells. To accomplish this objective, initially, we optimized the concentration of PAX and CLZ by determining cell viability through MTT assay. CompuSyn software was used to depict the synergistic, additive or antagonist effect of PAX and CLZ in combination. MTT assay and CompuSyn simulations suggest the synergistic activity of PAX and CLZ at 12.5-nM and 25-and#956;M respectively and nominated as PACL. Fluorescent microscopy also supports our finding, where PACL significantly induced nuclear damage in breast cancer cells (MCF-7 and MDA-MB-231). Oxidative stress and nitrogen stress was also aggravated by PACL when compared to individual drug concentration. PACL exhibited significant genotoxicity in cancerous cells whereas glucose uptake was inhibited remarkably through PACL in contrast to individual drug concentration. The second objective was to formulated surface functionalized SA polymeric nanoparticles (SA-PCL-NPs) of PAX. Carbodiimide reaction was exploited to mount SA on the surface of PCL-NPs. Characterisation reveals that SA-PCL-NPs were having spherical morphology with a size range of 151.5 nm to 179.47 nm. SA-PCL-NPs profoundly homed themselves inside the cancer cells and induces apoptosis as suggested by MTT assay and photoluminescence study. newlineWhile in the third objective different variables, that play an integral role in the development of nano-formulation were optimized through response surface methodology (RSM). Box Behnken Design (BBD) was employed to generate 3-dimensional surface plots and further analyzed to study the effect of variables on the particle size (PS) and entrapment efficiency % (%EE). Results suggest that when the optimized concentration of variables will be used, there would be 92.4% chances to get PS of 178.7 nm and %EE of 49.13% and witnessed that
dc.description.note
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extentxxvii, 133p
dc.identifier.urihttp://hdl.handle.net/10603/281814
dc.languageEnglish
dc.publisher.institutionDepartment of Pharmacy
dc.publisher.placeSolan
dc.publisher.universityJaypee University of Information Technology, Solan
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordBreast Cancer
dc.subject.keywordClinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
dc.subject.keywordClotrimazole
dc.subject.keywordCytotoxicity
dc.subject.keywordDrug delivery
dc.subject.keywordDrug release
dc.subject.keywordNano-formulation
dc.subject.keywordPaclitaxel
dc.titleDevelopment of Targeted Drug Delivery System for Breast Cancer
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 10
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
29.46 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_certificate;declaration;acknowledgement.pdf
Size:
780.52 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_table of contents;list of tables & figures; abb;abstract.pdf
Size:
570.87 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_chapter 1.pdf
Size:
4.08 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_ chapter 2.pdf
Size:
1.26 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: